Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Allurion Technologies, Inc. Common Stock (NY:ALUR)

3.200 -0.060 (-1.84%)
Official Closing Price Updated: 7:00 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Allurion Technologies, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Top movers in Friday's session
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Allurion Technologies Shares Are Up Today: What's Going On?
Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to conduct a clinical study evaluating the combination of its Allurion Program... 
Via Benzinga
Dow Falls 100 Points; US Manufacturing PMI Rises In January
Via Benzinga
Topics Stocks
Friday's session: gap up and gap down stocks
In today's session, there are notable price gaps in the US markets on Friday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Earnings Scheduled For November 13, 2024
Via Benzinga
A Look Ahead: Allurion Technologies's Earnings Forecast
Via Benzinga
Allurion Catapults 200% On Its Plans To Outdo Eli Lilly, Novo Nordisk
While the other companies are testing weight-loss drugs, Allurion has a different approach to obesity. 
Via Investor's Business Daily
US Stocks Mixed; Verizon Posts Upbeat Sales
Via Benzinga
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
Via Benzinga
US Stocks Set To Open Lower After Bank Of Japan Rate Hike: Analyst Recommends 'Overweight' Equities Despite Negative Market Breadth
U.S. stock futures fell on Friday following a 25 basis point rate hike by the Bank of Japan. Futures of all four indices declined. 
Via Benzinga
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Allurion Announces Positive Topline Results From AUDACITY Trial
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Allurion Technologies, Inc. Announces Reverse Stock Split
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance
From Allurion Technologies, Inc.
Via Business Wire
Why Vision Marine Technologies Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
From Allurion Technologies, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference
From Allurion Technologies, Inc.
Via Business Wire
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
From Allurion Technologies, Inc.
Via Business Wire
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
From Allurion Technologies, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.